Tyson Kim
Algemeen Directeur bij SYNTEKABIO, INC.
Actieve functies van Tyson Kim
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SYNTEKABIO, INC. | Algemeen Directeur | 01-01-2015 | - |
Radexel Co. Ltd.
 Radexel Co. Ltd. Medical SpecialtiesHealth Technology Radexel Co. Ltd. is a medical technology company based in Seoul, KR. The company was founded in 2018 by CEO Tyson Kim on the basis of Seoul Asan Medical Center development technology. Radexel is developing a radiation therapy device that treats cancer precisely with the world's first developed magnetic-radiation fusion technology and AI treatment plan. The device reduces side effects of normal tissue adjacent to cancer and improves treatment effect. It is also low-cost and compact, and can be installed in the same space as the existing radiation therapy device. | Algemeen Directeur | - | - |
Loopbaan van Tyson Kim
Statistieken
Internationaal
| Verenigde Staten | 2 |
| Zuid-Korea | 2 |
Operationeel
| Chief Executive Officer | 2 |
Sectoraal
| Technology Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SYNTEKABIO, INC. | Technology Services |
| Bedrijven in privébezit | 1 |
|---|---|
Radexel Co. Ltd.
Radexel Co. Ltd. Medical SpecialtiesHealth Technology Radexel Co. Ltd. is a medical technology company based in Seoul, KR. The company was founded in 2018 by CEO Tyson Kim on the basis of Seoul Asan Medical Center development technology. Radexel is developing a radiation therapy device that treats cancer precisely with the world's first developed magnetic-radiation fusion technology and AI treatment plan. The device reduces side effects of normal tissue adjacent to cancer and improves treatment effect. It is also low-cost and compact, and can be installed in the same space as the existing radiation therapy device. | Health Technology |
